DIA465.44+2.25 0.49%
SPY654.49+4.15 0.64%
QQQ583.22+6.04 1.05%

Canopy Growth’s Apollo Cannabis Clinics Named Best Medical Cannabis Clinic

Barchart·03/30/2026 06:30:00
Listen to the news

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that its Apollo Cannabis Clinics (“Apollo”) has been named Best Medical Cannabis Clinic in the 2025 Toronto Star’s Readers’ Choice Awards, a public vote that reflects the trust patients place in Apollo’s care.

Apollo represents the Company’s commitment to raising the standard of medical cannabis and making quality treatment accessible to every Canadian.

“This recognition comes directly from the people we care for, and that makes it especially meaningful,” said Luc Mongeau, Chief Executive Officer of Canopy Growth. “Everything Apollo does is grounded in genuine commitment to positive patient outcomes and our team works hard to make medical cannabis care accessible and supportive. To have that trusted by so many Canadians is something we don’t take lightly.”

Apollo provides Canada-wide access to free, fully virtual medical cannabis consultations – no referral required. Patients receive personalized treatment plans, ongoing education, and continuous support. To date, Apollo has helped thousands of Canadians manage chronic pain, anxiety, sleep disorders, PTSD, and other complex conditions through evidence-based care.

The annual Toronto Star’s Readers’ Choice Awards are determined entirely by public vote, with the public nominating and selecting the businesses they trust most across hundreds of categories.

About Canopy Growth

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, Claybourne, MTL Cannabis, Low Key by MTL, and R'belle, as well as category defining vaporization devices by Storz & Bickel.

Canopy Growth is Canada’s leading provider of medical cannabis services. Through Canada House Clinics Inc., the Company operates clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. Abba Medix, Canopy Growth’s established online medical channel, serves as a leading distributor of medical cannabis in Canada, together expanding the Company’s ability to reach and support patients nationwide and internationally.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA’s portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.

At Canopy Growth, we’re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we’re paving the way for a better understanding of all that cannabis can offer.

For more information visit www.canopygrowth.com.

About Apollo Cannabis Clinics

Apollo Cannabis Clinics is Canada's leading network of medical cannabis clinics, providing free, fully virtual care to patients across the country. Founded on a foundation of clinical research, Apollo connects Canadians with licensed healthcare practitioners for personalized, evidence-based medical cannabis treatment. Learn more at apollocannabis.ca.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.